Genmab A/SGMABNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+8.4%
5Y CAGR+4.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+8.4%/yr
vs +46.0%/yr prior
5Y CAGR
+4.8%/yr
Recent acceleration
Acceleration
-37.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.97B | +18.9% |
| 2024 | $6.70B | +26.0% |
| 2023 | $5.32B | -15.1% |
| 2022 | $6.27B | +112.2% |
| 2021 | $2.95B | -53.2% |
| 2020 | $6.31B | +139.3% |
| 2019 | $2.64B | +91.1% |
| 2018 | $1.38B | +2.7% |
| 2017 | $1.34B | +27.7% |
| 2016 | $1.05B | - |